|
|||||
A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round. . . . → Read More: A.I. Drug Discovery Company Gains $32M in Early Funds 
A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled 
Our friends at CB Insights put together a chart showing Amazon’s largest acquisitions in dollar value, this weekend’s infographic. . . . → Read More: Infographic – Amazon’s Largest Acquisitions 
A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO  Comments are closed  Finance  biomedical, cancer, clinical trials, entrepreneurs, equity, Europe, investment, IPO, life sciences, pharmaceuticals, U.K., university 
A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS. . . . → Read More: $3.4M NIH Grant Funding New ALS Treatments Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, grant, investment, life sciences, NIH, pharmaceuticals, preclinical, university 
A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods. . . . → Read More: Bacterial Genome Recoded to Produce Stable Protein Drugs One comment - (Comments are closed) New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital 
A technology for cancer therapies that harnesses the immune system with nanoscale droplets suspended in an emulsion and delivered through the nose received a U.S. patent. . . . → Read More: Patent Awarded for Nasal Delivered Cancer Immunotherapy Comments are closed Intellectual property biomedical, biotechnology, cancer, equity, investment, licensing, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, university 
The U.S. Food and Drug Administration authorized marketing of software to help diagnose wrist fractures using machine-learning algorithms to read and interpret X-ray images. . . . → Read More: FDA Okays A.I.-Guided Wrist Fracture Software Comments are closed New products, Regulations biomedical, engineering, equity, FDA, investment, life sciences, mathematics, medical device, physical sciences, software 
In a report this week, our friends at CB Insights note that the investment community is waiting for graphene to reach a critical commercial mass, but their patience may be running out. . . . → Read More: Infographic – Graphene Investment in Decline One comment - (Comments are closed) Finance engineering, entrepreneurs, equity, investment, materials science, nanotechnology, physical sciences, U.K., venture capital 
A medical device company is licensing a minimally-invasive technology developed in university labs for detection of Barrett’s esophagus, a condition that often leads to esophageal cancer. . . . → Read More: Univ. Licenses Barrett’s Esophagus Detection Device 2 comments - (Comments are closed) Intellectual property biomedical, cancer, clinical trials, engineering, equity, licensing, life sciences, medical device, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
